Beijing/ Boston – (March 10, 2015) – Joslin Diabetes Center and Sunshine Insurance Group Corporation Limited have announced today that they are collaborating to design and develop a Diabetes Center of Excellence in Weifang, Shandong Province, China. Located in Boston, Massachusetts, Joslin is the world's leading diabetes research, clinical care and education organization dedicated to the prevention, treatment and cure of diabetes. Joslin is an independent, non-profit institution affiliated with Harvard Medical School. Sunshine, founded in 2005, is one of China’s largest insurance companies, providing property, and casualty and life insurance service nationwide, the company is now actively getting into healthcare industry. 

The design and development of the Diabetes Center of Excellence will begin in 2015 and extend for one year.  The project will include planning for high-quality diabetes outpatient and inpatient management at the Sunshine Union Medical Center.  Joslin will establish an office in Beijing in order to facilitate the project and represent Joslin’s efforts in China.

William Hsu, M.D., Vice President of International Programs at Joslin and Assistant Professor at Harvard Medical School, noted, “Joslin is privileged to have 116 years of experience in diabetes care and we  extend our expertise beyond the walls of our campus in Boston.  Joslin has trained leaders in diabetes care from all over the world through our research fellows and visiting scholars program and has an extensive alumni network in China.  Joslin-trained, China-based physicians and scientists are the link to deepen our connection with China and broaden our global impact.”

Mr. Zhao Zongren, Vice President of Sunshine Insurance Group, noted “Healthcare industry will be one of our major investment areas in the next ten years. Great potentials abound in our partnership.  Joslin’s concept, technology and academic excellence will provide standardized treatment to diseases via Sunshine’s invested institutions.  We deliver excellent service with patient’s demand as our top priority. We will build a new healthcare layout by introducing new mechanism, learn from the successful cases around the world, open up the entire medical industry chain and enhance our management capabilities.”

An estimated 114 million people in China had diabetes in 2010, making China the country with the world’s largest diabetes population. Joslin is committed to reaching out to like-minded partners around the world.

###

Related Articles

A Scientist working in lab
Type 1
Kidney Disease
Research Highlights

The Preventing Early Renal Loss in Diabetes (PERL) Study Conclusion

The Preventing Early Renal Loss in Diabetes (PERL) Study Conclusion

Three-year clinical trial finds reducing uric acid levels in type 1 diabetes provides no beneficial impact on the progression of diabetic kidney disease BOSTON – (November 8, 2019) – Diabetic kidney...
Read more on The Preventing Early Renal Loss in Diabetes (PERL) Study Conclusion
National Diabetes Month
Type 1
Type 2

National Diabetes Awareness Month

National Diabetes Awareness Month

Diabetes is growing at an epidemic rate in the United States and across the globe. According to the Centers for Disease Control and Prevention (CDC), over 30 million Americans have diabetes and 1.5...
Read more on National Diabetes Awareness Month
Red blood cell traveling in an artery
Type 1
Heart Disease
Research Highlights

Research may show way to minimize complications after heart treatment

Research may show way to minimize complications after heart treatment

BOSTON – (October 1, 2019) – People with diabetes are much more likely to develop heart disease than those without the condition. They also are several times more likely to develop complications after...
Read more on Research may show way to minimize complications after heart treatment